23 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
, and similar anti-bribery and anti-corruption laws.
Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption … laws, regulations or rules of other countries in which we operate, including the U.K. Bribery Act. The FCPA generally prohibits offering, promising
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
Practices Act, or FCPA, and similar anti-bribery and anti-corruption laws.
Our business activities may be subject to the FCPA and similar anti-bribery … or anti-corruption laws, regulations or rules of other countries in which we operate, including the U.K. Bribery Act. The FCPA generally prohibits
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
16 May 22
Entry into a Material Definitive Agreement
9:49pm
and Development Convention on Bribery of Foreign Public Officials in International Business Transactions, and the rules and regulations thereunder
424B4
hbltua 08
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
dgq87oas
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
k4lx5qz
2 Jun 21
Draft registration statement
12:00am
DRS
EX-1.1
ffhc31e2
2 Jun 21
Draft registration statement
12:00am
10-K
u0ecg84n
31 Mar 21
Annual report
2:14pm
424B4
t2vceygz3s9a
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
EX-10.14
d2dlj4njopn0ti
23 Jul 20
IPO registration
12:28pm